Ulkan Kilic Selected Research

1,2-didecanoyl-3-phosphatidic acid (PA(10))

1/2005	Tissue plasminogen activator-induced ischemic injury is reversed by NMDA antagonist MK-801 in vivo.
4/2004	Melatonin reduces disseminate neuronal death after mild focal ischemia in mice via inhibition of caspase-3 and is suitable as an add-on treatment to tissue-plasminogen activator.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ulkan Kilic Research Topics

Disease

25	Brain Ischemia (Cerebral Ischemia) 05/2022 - 05/2003
19	Ischemia 12/2021 - 11/2002
18	Stroke (Strokes) 05/2022 - 05/2003
15	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 05/2022 - 01/2005
15	Infarction (Infarctions) 01/2022 - 03/2004
11	Ischemic Stroke 01/2022 - 11/2004
10	Brain Edema (Cerebral Edema) 01/2022 - 01/2005
10	Brain Injuries (Brain Injury) 05/2017 - 01/2004
7	Inflammation (Inflammations) 12/2021 - 10/2006
4	Alzheimer Disease (Alzheimer's Disease) 12/2020 - 03/2018
4	Reperfusion Injury 01/2020 - 02/2005
4	Neoplasms (Cancer) 01/2020 - 01/2013
4	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2019 - 04/2014
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2018 - 01/2014
3	Edema (Dropsy) 01/2020 - 02/2005
3	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2018 - 11/2006
3	Coronary Artery Disease (Coronary Atherosclerosis) 09/2018 - 04/2015
3	Optic Nerve Injuries 01/2005 - 01/2004
2	Obesity 01/2018 - 04/2015
2	Type 2 Diabetes Mellitus (MODY) 10/2015 - 06/2015
2	Atherosclerosis 04/2015 - 11/2008
2	Gliosis 01/2011 - 08/2009
2	Tuberculosis (Tuberculoses) 07/2004 - 01/2004
2	Leprosy (Hansen's Disease) 07/2004 - 01/2004
1	Amyloid Plaque 12/2020
1	Breast Neoplasms (Breast Cancer) 01/2020
1	Sepsis (Septicemia) 01/2020
1	Wounds and Injuries (Trauma) 01/2020
1	Degloving Injuries 01/2020
1	Cognitive Dysfunction 01/2020
1	Prediabetic State (Prediabetes) 01/2020
1	Carcinogenesis 01/2020
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2019
1	ST Elevation Myocardial Infarction 01/2019
1	Disease Susceptibility (Diathesis) 01/2019
1	Myocardial Infarction 01/2019
1	Parkinson Disease (Parkinson's Disease) 01/2019
1	Multiple Sclerosis 01/2019
1	Huntington Disease (Huntington's Disease) 01/2019
1	Dementia (Dementias) 10/2018

Drug/Important Bio-Agent (IBA)

14	MelatoninIBA 05/2022 - 04/2004
14	Proteins (Proteins, Gene)FDA Link 01/2020 - 05/2003
8	Neuroprotective AgentsIBA 01/2020 - 01/2004
8	Sirtuin 1IBA 01/2019 - 01/2014
7	AntioxidantsIBA 01/2019 - 11/2004
5	Phosphotransferases (Kinase)IBA 01/2018 - 09/2005
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2012 - 01/2005
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 03/2012 - 06/2006
4	Caspase 3 (Caspase-3)IBA 12/2007 - 04/2004
4	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 05/2006 - 05/2003
4	Tissue Plasminogen Activator (Alteplase)FDA Link 09/2005 - 03/2004
3	SirtuinsIBA 10/2018 - 01/2018
3	Rifampin (Rifampicin)FDA LinkGeneric 03/2018 - 01/2004
3	Free RadicalsIBA 01/2016 - 03/2004
3	Erythropoietin FDA Link 01/2011 - 02/2005
3	indoleIBA 09/2005 - 11/2004
3	cresyl violetIBA 04/2004 - 11/2002
2	CytokinesIBA 12/2021 - 12/2007
2	Biological ProductsIBA 12/2021 - 03/2012
2	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 01/2008
2	Dihydrotachysterol (AT 10)IBA 01/2020 - 05/2017
2	Pharmaceutical PreparationsIBA 01/2020 - 07/2004
2	Minocycline (Cyclops)FDA LinkGeneric 01/2020 - 01/2019
2	Ethanol (Ethyl Alcohol)IBA 01/2019 - 04/2014
2	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2019 - 04/2015
2	MicroRNAs (MicroRNA)IBA 09/2018 - 05/2016
2	Therapeutic UsesIBA 05/2017 - 12/2007
2	Immunoglobulin G (IgG)IBA 01/2017 - 10/2015
2	N-Methylaspartate (NMDA)IBA 01/2016 - 01/2005
2	Oxygen (Dioxygen)IBA 10/2015 - 01/2008
2	Coenzyme A (CoA)IBA 04/2015 - 02/2005
2	Oxidoreductases (Dehydrogenase)IBA 04/2015 - 02/2005
2	Drinking WaterIBA 04/2014 - 09/2008
2	Cisplatin (Platino)FDA LinkGeneric 01/2014 - 01/2013
2	Nitric Oxide Synthase (NO Synthase)IBA 06/2006 - 02/2005
2	1,2-didecanoyl-3-phosphatidic acid (PA(10))IBA 01/2005 - 04/2004
2	TransferasesIBA 04/2004 - 01/2004
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2022
1	1- (2- fluoro- 4- (1H- pyrazol- 1- yl)phenyl)- 5- methoxy- 3- (1- phenyl- 1H- pyrazol- 5- yl)pyridazin- 4(1H)- oneIBA 01/2022
1	fluoro-jade CIBA 12/2020
1	Congo RedIBA 12/2020
1	thymoquinoneIBA 12/2020
1	Amyloid (Amyloid Fibrils)IBA 12/2020
1	Phosphates (Orthophosphate)IBA 01/2020
1	Indicators and Reagents (Reagents)IBA 01/2020
1	Secretory Proteinase Inhibitory ProteinsIBA 01/2020
1	Stavudine (Zerit)FDA LinkGeneric 01/2020
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2020
1	Pentoxifylline (Trental)FDA LinkGeneric 01/2020
1	stampidineIBA 01/2020
1	sivelestatIBA 01/2020
1	9,10-Dimethyl-1,2-benzanthraceneIBA 01/2020
1	Oxidants (Oxidizing Agents)IBA 01/2019
1	Interleukin-7 (Interleukin 7)IBA 10/2018
1	Toll-Like Receptor 4IBA 10/2018

Therapy/Procedure

7	Therapeutics 01/2022 - 05/2003
3	Lasers (Laser) 10/2015 - 04/2004
3	Axotomy 07/2008 - 02/2005
2	Drug Therapy (Chemotherapy) 01/2020 - 10/2008
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 09/2018 - 05/2016